Bausch Health Companies

Incorporated in 1959, Bausch Health Companies Inc., originally known as Valeant Pharmaceuticals, has established its headquarters in Laval, Quebec, Canada. Bausch Health is a diverse pharmaceutical company that operates through four main business segments. The Bausch + Lomb/International segment is renowned for its extensive range of eye health products that includes contact lenses, intraocular lenses, as well as various ophthalmic surgical products. This segment emphasizes quality and innovation in its offerings to support the eye health of consumers. The Salix division of Bausch Health focuses on gastroenterology products and is known for well-recognized brands such as Xifaxan and Uceris. These products address medical needs in the area of gastrointestinal health and have a strong market presence. Another integral business category within Bausch Health is Ortho Dermatologics. This segment offers an array of dermatological products, including notable brands like Jublia, used for treating fungal nail infections, and Elidel, for eczema management. The Diversified Products segment caters to various healthcare needs, spanning neurology and other therapeutic classes. This segment includes established brands such as the antidepressant Wellbutrin. Adding to their diversified portfolio, the Solta brand underlines Bausch Health's involvement in the medical aesthetic device industry. Bausch Health's products and services command a substantial global footprint with the United States as a key market. Moreover, the company's international outreach extends to regions across Europe, Asia Pacific, and Latin America, where its strategic operations adapt to varying market conditions. (Powered by AI)